Community Pharmacy & MOUD

Session from the 2025 Overdose Awareness Series

Community pharmacies are highly accessible points of care and pharmacy staff are adequately equipped to potentially provide care for opioid use disorder (OUD) patients. A series of interviews were collected and analyzed between January to May 2024 by the University of Washington, School of Pharmacy and the Washington State Pharmacy Association through a grant-funded study. Pharmacy staff, prescribers and program administrators of MOUD programs, and those with lived experience were interviewed to look at the viability of having a community pharmacy be a point of access for care for patients needing medications for opioid use disorder (MOUD). The study was analyzed using PRISM and resulted in two models of care that could be implemented in the community pharmacy setting.

Learning Objectives: By the end of this session, attendees will
· Define community pharmacy and MOUD
· Identify how a community pharmacy can have an impact in the MOUD space
· Recognize two different models of care that can be implemented in a community pharmacy to provide care for OUD patients

Speakers:
Boris Zhang, Washington State Pharmacy Association, Director of Professional Affairs

Jennifer Bacci, PharmD, University of Washington School of Pharmacy, Endowed Associate Professor of Innovative Pharmacy Practice